Please use this identifier to cite or link to this item:
Title: Montelukast and cetrizine may ameliorate progression of rheumatoid arthritis.
Authors: Nimbalkar, Vikram V
Chikte, Deepali S
Gaikwad, Pandurang M
Keywords: Montelukast
rheumatoid arthritis
Issue Date: Jul-2016
Citation: Vikram V Nimbalkar, Deepali S Chikte, Pandurang M Gaikwad. Montelukast and cetrizine may ameliorate progression of rheumatoid arthritis. International Journal of Clinical and Biomedical Research. 2016 Jul-Sept; 2(3):34- 38.
Abstract: Rheumatoid arthritis is an autoimmune disorder. It is a chronic progressive disease resulting in inflammation of joints and painful deformity and immobility of various joints. Being an autoimmune disease, there’s lacuna in proper management of the disease. Current options like steroids and DMARD’S (disease modifying anti-rheumatic drugs) are the cornerstone in therapy of the disease, but have their own limitation. New drugs and better methods for management of rheumatoid arthritis are still evolving. The present review highlights the possible involvement of Montelukast, an antagonist of leukotriene receptors and Cetrizine, an antihistaminic drug in amelioration of the progression of the disease.
ISSN: 2395-0471
Appears in Collections:International Journal of Clinical and Biomedical Research (IJCBR)

Files in This Item:
File Description SizeFormat 
ijcbr2016v2n3p34.pdfReview article970.12 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.